Key Articles and Guidelines for the Prevention of Venous Thromboembolism

Paul P Dobesh, Ann K. Wittkowsky, Zachary Stacy, William E. Dager, Stuart T. Haines, Larry M. Lopez, Edith Nutescu, Katherine W. Phillips, Toby C. Trujillo, Tom Vondracek

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Venous thromboembolism (VTE) is an important medical problem that affects millions of patients each year. With appropriate prophylaxis, many of these thromboembolic events can be prevented. Although strong evidence supporting VTE prophylaxis spans several decades, several large American and global registries have documented very poor use of appropriate prophylaxis. Because of increasing regulatory requirements, hospitals nationwide are in the process of developing documentation of appropriate VTE prophylaxis programs for both surgical and medical patients. A wide range of clinicians must understand what constitutes appropriate VTE prophylaxis in various patient populations. With the existence of numerous pharmacologic agents, abundance of data from major clinical trials, and several nationally recognized clinical guidelines, compiling the needed reference material to make evidence-based decisions on appropriate VTE prophylaxis can be difficult for clinicians. Therefore, we provide a bibliography of key articles and guidelines related to the prevention of VTE in various patient groups. We hope this compilation will serve as a resource for pharmacists, physicians, nurses, residents, and students responsible for the care of patients who may be at risk for VTE.

Original languageEnglish (US)
Pages (from-to)410-458
Number of pages49
JournalPharmacotherapy
Volume29
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Venous Thromboembolism
Guidelines
Bibliography
Pharmacists
Documentation
Registries
Patient Care
Nurses
Clinical Trials
Students
Physicians
Population

Keywords

  • Anticoagulation
  • Evidence-based medicine
  • Pharmacy practice

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Dobesh, P. P., Wittkowsky, A. K., Stacy, Z., Dager, W. E., Haines, S. T., Lopez, L. M., ... Vondracek, T. (2009). Key Articles and Guidelines for the Prevention of Venous Thromboembolism. Pharmacotherapy, 29(4), 410-458. https://doi.org/10.1592/phco.29.4.410

Key Articles and Guidelines for the Prevention of Venous Thromboembolism. / Dobesh, Paul P; Wittkowsky, Ann K.; Stacy, Zachary; Dager, William E.; Haines, Stuart T.; Lopez, Larry M.; Nutescu, Edith; Phillips, Katherine W.; Trujillo, Toby C.; Vondracek, Tom.

In: Pharmacotherapy, Vol. 29, No. 4, 01.04.2009, p. 410-458.

Research output: Contribution to journalReview article

Dobesh, PP, Wittkowsky, AK, Stacy, Z, Dager, WE, Haines, ST, Lopez, LM, Nutescu, E, Phillips, KW, Trujillo, TC & Vondracek, T 2009, 'Key Articles and Guidelines for the Prevention of Venous Thromboembolism', Pharmacotherapy, vol. 29, no. 4, pp. 410-458. https://doi.org/10.1592/phco.29.4.410
Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Haines ST, Lopez LM et al. Key Articles and Guidelines for the Prevention of Venous Thromboembolism. Pharmacotherapy. 2009 Apr 1;29(4):410-458. https://doi.org/10.1592/phco.29.4.410
Dobesh, Paul P ; Wittkowsky, Ann K. ; Stacy, Zachary ; Dager, William E. ; Haines, Stuart T. ; Lopez, Larry M. ; Nutescu, Edith ; Phillips, Katherine W. ; Trujillo, Toby C. ; Vondracek, Tom. / Key Articles and Guidelines for the Prevention of Venous Thromboembolism. In: Pharmacotherapy. 2009 ; Vol. 29, No. 4. pp. 410-458.
@article{09a1b5e707724baaa7bcb11eaa4daf71,
title = "Key Articles and Guidelines for the Prevention of Venous Thromboembolism",
abstract = "Venous thromboembolism (VTE) is an important medical problem that affects millions of patients each year. With appropriate prophylaxis, many of these thromboembolic events can be prevented. Although strong evidence supporting VTE prophylaxis spans several decades, several large American and global registries have documented very poor use of appropriate prophylaxis. Because of increasing regulatory requirements, hospitals nationwide are in the process of developing documentation of appropriate VTE prophylaxis programs for both surgical and medical patients. A wide range of clinicians must understand what constitutes appropriate VTE prophylaxis in various patient populations. With the existence of numerous pharmacologic agents, abundance of data from major clinical trials, and several nationally recognized clinical guidelines, compiling the needed reference material to make evidence-based decisions on appropriate VTE prophylaxis can be difficult for clinicians. Therefore, we provide a bibliography of key articles and guidelines related to the prevention of VTE in various patient groups. We hope this compilation will serve as a resource for pharmacists, physicians, nurses, residents, and students responsible for the care of patients who may be at risk for VTE.",
keywords = "Anticoagulation, Evidence-based medicine, Pharmacy practice",
author = "Dobesh, {Paul P} and Wittkowsky, {Ann K.} and Zachary Stacy and Dager, {William E.} and Haines, {Stuart T.} and Lopez, {Larry M.} and Edith Nutescu and Phillips, {Katherine W.} and Trujillo, {Toby C.} and Tom Vondracek",
year = "2009",
month = "4",
day = "1",
doi = "10.1592/phco.29.4.410",
language = "English (US)",
volume = "29",
pages = "410--458",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Key Articles and Guidelines for the Prevention of Venous Thromboembolism

AU - Dobesh, Paul P

AU - Wittkowsky, Ann K.

AU - Stacy, Zachary

AU - Dager, William E.

AU - Haines, Stuart T.

AU - Lopez, Larry M.

AU - Nutescu, Edith

AU - Phillips, Katherine W.

AU - Trujillo, Toby C.

AU - Vondracek, Tom

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Venous thromboembolism (VTE) is an important medical problem that affects millions of patients each year. With appropriate prophylaxis, many of these thromboembolic events can be prevented. Although strong evidence supporting VTE prophylaxis spans several decades, several large American and global registries have documented very poor use of appropriate prophylaxis. Because of increasing regulatory requirements, hospitals nationwide are in the process of developing documentation of appropriate VTE prophylaxis programs for both surgical and medical patients. A wide range of clinicians must understand what constitutes appropriate VTE prophylaxis in various patient populations. With the existence of numerous pharmacologic agents, abundance of data from major clinical trials, and several nationally recognized clinical guidelines, compiling the needed reference material to make evidence-based decisions on appropriate VTE prophylaxis can be difficult for clinicians. Therefore, we provide a bibliography of key articles and guidelines related to the prevention of VTE in various patient groups. We hope this compilation will serve as a resource for pharmacists, physicians, nurses, residents, and students responsible for the care of patients who may be at risk for VTE.

AB - Venous thromboembolism (VTE) is an important medical problem that affects millions of patients each year. With appropriate prophylaxis, many of these thromboembolic events can be prevented. Although strong evidence supporting VTE prophylaxis spans several decades, several large American and global registries have documented very poor use of appropriate prophylaxis. Because of increasing regulatory requirements, hospitals nationwide are in the process of developing documentation of appropriate VTE prophylaxis programs for both surgical and medical patients. A wide range of clinicians must understand what constitutes appropriate VTE prophylaxis in various patient populations. With the existence of numerous pharmacologic agents, abundance of data from major clinical trials, and several nationally recognized clinical guidelines, compiling the needed reference material to make evidence-based decisions on appropriate VTE prophylaxis can be difficult for clinicians. Therefore, we provide a bibliography of key articles and guidelines related to the prevention of VTE in various patient groups. We hope this compilation will serve as a resource for pharmacists, physicians, nurses, residents, and students responsible for the care of patients who may be at risk for VTE.

KW - Anticoagulation

KW - Evidence-based medicine

KW - Pharmacy practice

UR - http://www.scopus.com/inward/record.url?scp=64849099043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64849099043&partnerID=8YFLogxK

U2 - 10.1592/phco.29.4.410

DO - 10.1592/phco.29.4.410

M3 - Review article

VL - 29

SP - 410

EP - 458

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 4

ER -